Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Acute exposure to nickel activates hypoxia-inducible transcription factor-1 (HIF-1), which strongly induces hypoxia-inducible genes, including the recently discovered tumor marker Cap43.
|
12426141 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In this study we examined whether and how NDRG1/Cap43 modulates tumor growth by human hepatocellular carcinoma (HCC) cells.
|
21775055 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The observation that NDRG1 completely inhibited growth in anchorage-independent assays and in vivo supports a biological function as a tumor suppressor in pancreatic cancer.
|
21236457 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Sterol regulation of NDRG1 transcription suggests its potential as biomarker for prediction of neoplasms that would be responsive to chemoprevention by phytosterols.
|
20466611 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Further studies examining the downstream effects of NEDD4L led to the discovery that NDRG1 affects the transforming growth factor-β (TGF-β) pathway, leading to the upregulation of two key tumor suppressor proteins, namely phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and mothers against decapentaplegic homolog-4 (SMAD4).
|
22462691 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The N-myc downstream regulated gene 1 (NDRG1) is significantly associated with advanced tumor stages and poor survival of hepatocellular carcinoma (HCC), thereby implicating it as a potential target for HCC treatment.
|
26359353 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our findings reinforce the idea that NDRG1 plays a metastasis suppressor role in oral and oropharyngeal squamous cell carcinomas and may be a useful marker for these tumors.
|
22972152 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
NDRG1 inhibited tumor proliferation through increasing p21 expression via suppressing p21 ubiquitylation.
|
31831018 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In Japanese patients with stages II and III tumors, strong NDRG1 staining in p53-positive tumors correlated significantly with improved survival but negatively in patients without chemotherapy.
|
17569115 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We investigated the expression of NDRG1 in pancreatic cancer tissues and cell lines as well as how it affects tumor growth, invasion and migration in pancreatic cancer cells.
|
28075464 |
2017 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
Furthermore, the NDRG1 promoter methylation correlated with the Tumor Node Metastasis (TNM) at stage III/IV, metastasis, lymph invasion, moderate and poor histological grade in the breast cancer patients.
|
23899187 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Currently regarded as a tumor suppressor in most studies, NDRG1 is abundant in prostate, brain, kidney, placental, and intestinal tissues.
|
29283328 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The influence of NDRG1 silencing on cancer cell biological behaviors was examined through observing in vitro tumor cell proliferation, colony formation, cell migration and invasion.
|
22678098 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Intriguingly, pSTAT6/C-C motif chemokine ligand 26 (CCL26) signaling is induced by FOXQ1/NDRG1 axis, thus recruiting hepatic stellate cells (HSCs), the main cellular source of CAFs, to the tumor microenvironment.
|
29248714 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
NDRG1 was detected at its protein level by immunohistochemistry in formalin-fixed and paraffin-embedded sections with a total of 110 pair gastric cancer specimens including tumor and corresponding paraneoplastic tissues; NDRG1 mRNA was detected by real time-polymerase chain reaction.
|
20388062 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
By contrast, Cap43 overexpression showed a marked decrease in tumor growth rates in vivo.
|
16778198 |
2006 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In a previous study, we have shown that N-myc downstream-regulated gene 1 (NDRG1), classified in databases as a tumor suppressor and heavy metal-response protein, is mutated in hereditary motor and sensory neuropathy Lom (HMSNL), a severe autosomal recessive form of Charcot-Marie-Tooth (CMT) disease.
|
12872253 |
2003 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
N-myc downstream-regulated gene 1 (NDRG1), important in tumor growth and metastasis, has recently gained interest as a potential therapeutic target.
|
20173668 |
2010 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemical staining was applied to detect NDRG1/Cap43-positive tumor cells, and real-time quantitative-PCR (RT-PCR) was used to determine mRNA transcript levels of NDRG1/Cap43 in lung cancer tissues.
|
22722710 |
2012 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Previously, we reported that N-myc downstream-regulated gene 1 (NDRG1) is strongly up-regulated under hypoxia and may play an important role in tumor adaptation to fluctuating oxygen concentrations.
|
26852918 |
2016 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In particular, the MCPyV early gene downregulated the expression of the tumor suppressor gene N-myc downstream regulated gene-1 (NDRG1) in NIKs-MCPyV and hTERT-MCPyV human keratinocytes (HK) as compared to their controls.
|
31694959 |
2020 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Diverse physiological and pathological conditions (hypoxia, cellular differentiation, heavy metal, N-myc, neoplasia) modulate NDRG1 transcription, mRNA stability, and translation.
|
12432451 |
2002 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Additionally, high levels of NDRG1 transcript correlated with shorter overall survival (P<0.001), late tumor stage (P=0.001), vascular invasion (P=0.003), large tumor size (P=0.011), and high Edmondson-Steiner histological grade (P=0.005).
|
17170744 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In conclusion, we demonstrated that NDRG1 acts as a tumor suppressor in ovarian carcinogenesis and may be a potential therapeutic target in this disease.
|
24626771 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our results verify that NDRG1 acts as a tumor suppressor gene and may play an important role in the metastasis progression and prognosis of gastric cancer.
|
24985974 |
2014 |